BACKGROUND: Deletion polymorphism of the UDP-glucuronosyltransferase 2B17 (UGT2B17) gene has been associated with an increased prostate cancer risk in two previous independent studies. Here we determine the risk in a large-scale population-based case-control study. METHODS: Genotyping was conducted with a 5'-nuclease activity assay to distinguish those with one or two UGT2B17 gene copies (ins/del and ins/ins) from individuals homozygous for the deletion (del/del) allele. RESULTS: In contrast to previous findings, no association between the UGT2B17 deletion polymorphism and prostate cancer risk was found. Furthermore the UGT2B17 gene deletion did not affect the risk for prostate cancer specific death. CONCLUSION: The UGT2B17 deletion polymorphism does not play a major role in prostate cancer susceptibility as previously indicated.
BACKGROUND: Deletion polymorphism of the UDP-glucuronosyltransferase 2B17 (UGT2B17) gene has been associated with an increased prostate cancer risk in two previous independent studies. Here we determine the risk in a large-scale population-based case-control study. METHODS: Genotyping was conducted with a 5'-nuclease activity assay to distinguish those with one or two UGT2B17 gene copies (ins/del and ins/ins) from individuals homozygous for the deletion (del/del) allele. RESULTS: In contrast to previous findings, no association between the UGT2B17 deletion polymorphism and prostate cancer risk was found. Furthermore the UGT2B17 gene deletion did not affect the risk for prostate cancer specific death. CONCLUSION: The UGT2B17 deletion polymorphism does not play a major role in prostate cancer susceptibility as previously indicated.
Authors: Matthew L Cooper; Hans-Olov Adami; Henrik Grönberg; Fredrik Wiklund; Fiona R Green; Margaret P Rayman Journal: Cancer Res Date: 2008-12-15 Impact factor: 12.701
Authors: Delores J Grant; Cathrine Hoyo; Shannon D Oliver; Leah Gerber; Katie Shuler; Elizabeth Calloway; Alexis R Gaines; Megan McPhail; Jonathan N Livingston; Ricardo M Richardson; Joellen M Schildkraut; Stephen J Freedland Journal: Genet Test Mol Biomarkers Date: 2012-10-25
Authors: Yali Xue; Donglin Sun; Allan Daly; Fengtang Yang; Xue Zhou; Mengyao Zhao; Ni Huang; Tatiana Zerjal; Charles Lee; Nigel P Carter; Matthew E Hurles; Chris Tyler-Smith Journal: Am J Hum Genet Date: 2008-08-28 Impact factor: 11.025
Authors: Mohammed Uddin; Walter P Maksymowych; Robert Inman; Dafna Gladman; Alexandra Munn; Ramin Yazdani; Fawnda Pellett; Sean Hamilton; Darren D O'Rielly; Proton Rahman Journal: BMC Genet Date: 2013-08-08 Impact factor: 2.797
Authors: Adriana C Vidal; Cocoa Tucker; Joellen M Schildkraut; Ricardo M Richardson; Megan McPhail; Stephen J Freedland; Cathrine Hoyo; Delores J Grant Journal: BMC Cancer Date: 2013-11-22 Impact factor: 4.430